Survival in @entity1 with primary @entity96 , XXXX and @entity788 in Europe 1999-2007: Results of EUROCARE-5.

@entity1 @entity788 @entity96 @entity5 @entity1125
BACKGROUND: The EUROCARE study collects and analyses survival data from population-based @entity5 registries (CRs) in Europe in order to provide data on between-country differences in survival and time trends in survival. METHODS: This study analyses data on @entity96 , @entity1125 (" @entity1125 "), and @entity788 diagnosed in 2000-2007 from 88 CRs in 29 countries. Relative survival (RS) was estimated overall, by region, sex, age and period of diagnosis using the complete approach. Time trends in 5-year RS over 1999-2007 were also analysed using the period approach. RESULTS: The prognosis of the studied @entity5 was poor. Age-standardised 5-year RS was 12% for @entity96 , 17% for @entity1125 and 7% for @entity788 . There were some between-country differences in survival. In general, RS was low in Eastern Europe and high in Central and Southern Europe. For all sites, 5-year RS was similar in @entity1 and @entity1 and decreased with advancing age. No substantial changes in survival were reported for @entity788 over the period 1999-2007. On average, there was a crude increase in 5-year RS of 3 percentage points between the periods 1999-2001 and 2005-2007 for @entity96 and @entity1125 . CONCLUSIONS: The major changes in imaging techniques over the study period for the diagnosis of the three studied @entity5 did not result in an improvement in the prognosis of these @entity5 . In the near future, new innovative treatments might be the best way to improve the prognosis in these @entity5 .
